Cancer Survivorship in Stage 4 Kidney Cancer | Metastatic Disease | Denvax | Dr Sharmin
Kidney cancer is a common malignancy in adult male population, in India. In this video, we share a story of survivorship of a stage-4 kidney cancer patient, with metastasis in liver. He was distraught by the process of having taken surgery, with his removal of 1 kidney, and still no relief in complete removal of disease. He had already taken chemotherapy and radiation, post his surgery, yet he was not disease-free. Additionally, he was suffering from weakness and weight loss. He approached us in 2019 for Denvax treatment for his residual disease in liver. With Denvax, his lesion started to resolve and completely disappeared in 2020. He also completely regained his health.
Denvax is a simple and safe cancer treatment that is used in an adjuvant setting (as an additional treatment plan). It is mostly given as a combination approach along with chemotherapy, surgery and radiation. Denvax is almost devoid of side effects, being autologous, biological and a targeted treatment option.
Dr Jamal A. Khan and Dr Sharmin Yaqin have co-founded Denvax Cancer Immunotherapy. Together they have been in exclusive clinical practice of Dendritic cell therapy (Denvax) for the past 18 years. They pioneered the research in customized Immunotherapy in India in the year 2004.
Dr Sharmin, for over 15 years has been actively involved in the prevention of cancer. Her current research interest is in finding ways to prevent cancer and reduce the burden, suffering and mortality.
The Denvax clinics are owned and managed by Dr Jamal and Dr Sharmin. They comprise a team of doctors and paramedical staff who are engaged in administering of this customized treatment protocol.
They can be reached at contact@denvaxindia.com
Get in touch for you cancer care:
Toll Free: 1800 123 1123, 011 410 168, +91 93118 08420, +91 9625 150164
www.denvaxindia.com
-
Category
No comments found